Life Sciences Investing

Ampersand Capital Partners has announced it has sold portfolio company Adaptas Solutions to IMI.

Adaptas, based in Palmer, Mass., provides components for complex laboratory instruments in the life sciences, diagnostics and lab automation markets.

IMI, formerly Imperial Metal
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Ampersand Capital Sells Adaptas to IMI

Avesi Partners has announced it has invested in Danforth Advisors.

Danforth, based in Waltham, Mass., is a provider of strategic and operational finance and accounting for life science companies. The company states that it has served more than 750
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Avesi Invests in Danforth Advisors

LLR Partners has announced it has completed a growth investment in Genesee Scientific Corp.

Genesee Scientific, based in San Diego, is a manufacturer and distributor of products to life science markets. Founded in 1995, the company provides consumables and
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: LLR Invests in Genesee Scientific

Funds led by Carlyle have acquired a majority stake in Saama Technologies, according to a news release.

The investment is valued at up to $430 million.

Saama, based in Campbell, Calif., is an AI clinical analytics platform company.
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Carlyle and Other Funds Acquire Saama Technologies

Thompson Street Capital Partners has announced it has acquired Vector Laboratories.

Vector, based in Burlingame, Calif., is the protein detection business unit of Maravai. Founded in 1976, the company manufacturers labeling and visual detection reagents for life science
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Thompson Street Acquires Vector Laboratories

Sixth Street has led an $830 million growth equity investment into Caris Life Sciences, according to a news release.

Caris, based in Irving, Texas, develops molecular profiling assays for oncology that scan DNA, RNA and proteins to reveal
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Sixth Street Leads $830 Million Investment Into Caris Life Sciences

The Carlyle Group has announced it has agreed to acquire Unchained Labs for $435 million.

Unchained Labs, based in Pleasanton, Calif., is a producer of life sciences tools. Founded in 2015, the company focuses on solving problems for biologics
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Carlyle Group Acquires Unchained Labs for $435 Million